⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL269956 | 0.85 | — | — | |
| SCHEMBL181391 | 0.81 | CYP1A2 (0.40) | — | |
| SCHEMBL20391414 | 0.80 | — | — | |
| SCHEMBL18272516 | 0.80 | — | — | |
| SCHEMBL3403822 | 0.80 | — | — | |
| SCHEMBL7695260 | 0.79 | — | — | |
| SCHEMBL8484837 | 0.79 | — | — | |
| SCHEMBL27427744 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL29865820 | 0.79 | NPC1 (0.40) | — | |
| SCHEMBL6159345 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 852 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113683616-A | KRAS G12C mutein inhibitors | 广州百霆医药科技有限公司 | 2021-11-23 | — | — | CN | claimed |
| CN-109748870-B | Process for preparing indenoisoquinoline derivatives | 姚清发 | 2021-02-12 | — | — | CN | claimed |
| CN-109154604-A | Charged surface reverse phase chromatography material method for analysis of glycans modified with amphiphilic strongly basic moieties | 沃特世科技公司 | 2019-01-04 | — | — | CN | claimed |
| US-9550761-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-01-24 | — | — | US | claimed |
| EP-2045251-B1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | CONSEJO SUPERIOR INVESTIGACION (ES) | 2015-11-18 | — | — | EP | claimed |
| US-8785430-B2 | Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-07-22 | — | — | US | claimed |
| US-20140080825-A1 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-03-20 | — | — | US | claimed |
| US-20130345220-A1 | COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS | IRM LLC (BM) | 2013-12-26 | — | — | US | claimed |
| US-8541453-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-09-24 | — | — | US | claimed |
| US-20130237529-A1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS | 2013-09-12 | — | — | US | claimed |
| WO-2001030768-A9 | METHODS AND COMPOSITIONS UTILIZING QUINAZOLINONES | CYTOKINETICS INC (US) | 2002-08-15 | — | — | WO | claimed |
| EP-1226129-A1 | METHODS AND COMPOSITIONS UTILIZING QUINAZOLINONES | Cytokinetics, Inc. (US) | 2002-07-31 | — | — | EP | claimed |
| WO-2001098278-A1 | METHODS AND COMPOSITIONS UTILIZING QUINAZOLINONES | CYTOKINETICS, INC. (US) | 2001-12-27 | — | — | WO | claimed |
| EP-0571822-B1 | Diazabicycloalkene derivatives | DAIICHI SEIYAKU CO (JP) | 2001-08-16 | — | — | EP | claimed |
| WO-2001030768-A1 | METHODS AND COMPOSITIONS UTILIZING QUINAZOLINONES | CYTOKINETICS, INC. (US) | 2001-05-03 | — | — | WO | claimed |
| WO-1999062905-A1 | 8-PHENYLXANTHINE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | ALMIRALL PRODESFARMA, S.A. (ES) | 1999-12-09 | — | — | WO | claimed |
| US-5948696-A | LIBRARY OF COMPOUNDS LINKED TO SOLID SUPPORT; SUPPORT ALSO HAS IDENTIFIER MOLECULE (TAG); FOR USE IN SCREENING BIOLOGICALLY ACTIVE MOLECULES SUCH AS ENZYME INHIBITORS | PHARMACOPEIA, INC. (US) | 1999-09-07 | — | — | US | claimed |
| US-5418232-A | Hypotensive, increases renal blood flow | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1995-05-23 | — | — | US | claimed |
| US-5252732-A | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1993-10-12 | — | — | US | claimed |
| EP-0371467-A2 | Beta-amino boron acid derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-06 | — | — | EP | claimed |